THERAPY OF RESTENOSIS AND ATHEROSCLEROSIS WITH A SOLUBLE VEGF RECEPTOR AND ANGIOPOEITIN-1

摘要

Disclosed and claimed are compositions and methods for therapy and/or prevention of restenosis and/or atherosclerosis. The compositions can include an agent for inhibiting VEGF and an agent for including vessel maturation; for instance, the soluble VEGF receptor and ang-1. Embodiments can include kits.